Showing results (1-10 of 42) with videos related to
Sort By:
Pageof 5
Journal of Thoracic Disease|June 29, 2018
Is there a room for immune checkpoint inhibitors in early stage non-small cell lung cancer?Elisa Gobbini, Matteo Giaj LevraTranslational Lung Cancer Research|March 26, 2015
MET inhibition in lung cancerJessica Menis, Matteo Giaj Levra, Silvia NovelloCurrent Pharmaceutical Design|November 7, 2013
PARP inhibitors: an interesting pathway also for non-small cell lung cancer?Matteo Giaj Levra, Ken Andre Olaussen, Silvia Novello, et al.Bulletin Du Cancer|August 7, 2016
[Not Available]Denis Moro-Sibilot, Léonie Ferrer, Matteo Giaj Levra, et al.Translational Lung Cancer Research|August 25, 2021
Epidemiology of oligometastatic non-small cell lung cancer: results from a systematic review and pooled analysisElisa Gobbini, Luca Bertolaccini, Niccolò Giaj-Levra, et al.Seminars in Oncology|February 26, 2014
Extending survival of stage IV non-small cell lung cancerSimona Carnio, Silvia Novello, Teresa Mele, et al.Cancers|November 3, 2020
Advances and Therapeutic Perspectives in Extended-Stage Small-Cell Lung CancerThomas Pierret, Anne-Claire Toffart, Matteo Giaj Levra, et al.Bulletin Du Cancer|June 14, 2020
[Immunotherapy of metastatic non-small cell lung cancer from first line to resistance and its management]Clémence Basse, Aurelie Swalduz, Matteo Giaj Levra, et al.European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|January 1, 2008
Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patientsPiero Borasio, Alfredo Berruti, Andrea Billé, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 2, 2008
Fetal adenocarcinoma of the lung in a 25-year-old womanMarina Longo, Matteo Giaj Levra, Enrica Capelletto, et al.Pageof 5